In metastatic colon cancer, TERF2IP activates NFkB, leading to the phosphatase of regenerating liver 3 (PRL3) activation and increased TERF2IP expression and nuclear export, ultimately promoting cancer cell invasiveness and metastasis (378–381, 385). The gene discussed is TERF2IP; the disease is cancer.